Dr. Reddy's Laboratories share price
Dr. Reddy's Laboratories Ltd. · NSE: DRREDDY · Healthcare
Price, one year
Price range
- Open
- ₹1,236.20
- High
- ₹1,250.60
- Low
- ₹1,225.30
- Previous close
- ₹1,239.00
- Volume
- 7.4 L
- Market cap
- ₹1,02,340 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 32.0
- Price to book
- 2.7
- Return on equity
- 8.5%
- EPS (TTM)
- ₹38.69
- Book value / share
- ₹453.96
- Debt to equity
- 0.16
- Revenue (TTM)
- ₹33,228 Cr
- Net profit (TTM)
- ₹3,222 Cr
- Sales growth, YoY
- −5.5%
- Profit growth, YoY
- −68.7%
- Operating margin
- 15.5%
- Net margin
- 9.7%
- Sales CAGR, 3 years
- +11.0%
- Profit CAGR, 3 years
- −2.4%
- Promoter holding
- 26.63%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 26.63 | 26.64 | 26.63 |
| Foreign institutions | 33.08 | 32.07 | 31.39 |
| Domestic institutions | 30.72 | 31.74 | 31.88 |
| Mutual funds | 13.19 | 13.16 | 14.14 |
| Retail and others | 7.57 | 7.42 | 7.53 |
Futures and options
22 Oct 2026- Lot size
- 625
- Put-call ratio (OI)
- 0.62
- Max pain
- ₹1,210.00
- Highest call OI strike
- 1,200.00
- Highest put OI strike
- 1,200.00
- ATM implied volatility
- 29.9% IV rank 64
- Futures basis
- +0.22%
- Rollover
- 35.9%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 22 Oct | Long unwinding | −0.14% | −4.52% |
| 21 Oct | Long unwinding | −0.06% | −1.42% |
| 19 Oct | Long buildup | +0.85% | +1.46% |
| 16 Oct | Short covering | +0.81% | −0.02% |
| 15 Oct | Short covering | +0.64% | −1.37% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 22 Jul 2026. results: 23 Oct 2026.
- 21 Oct 2026 · Press releasePress ReleaseDr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Dr. Reddy s Receives DCGI Approval for Zytorvi® (toripalimab) in Advanced Esophageal Squamous Cell...
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,740.20 | −1.01% |
| Divi's LaboratoriesDIVISLAB | ₹8,882.00 | −3.06% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,487.50 | −2.77% |
| Zydus LifesciencesZYDUSLIFE | ₹1,124.70 | −0.91% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,579.00 | −0.34% |
| CiplaCIPLA | ₹1,318.90 | −0.90% |
| Laurus LabsLAURUSLABS | ₹1,943.40 | −2.95% |
| Mankind PharmaMANKIND | ₹2,229.50 | −2.03% |
| Aurobindo PharmaAUROPHARMA | ₹1,557.50 | −3.31% |
| LupinLUPIN | ₹1,906.60 | −0.80% |
Frequently asked questions
What is the share price of Dr. Reddy's Laboratories today?
Dr. Reddy's Laboratories (NSE: DRREDDY) was at ₹1,226.10 on 23 Oct 2026, a change of −1.04% from the previous close.
What are the 52-week high and low of Dr. Reddy's Laboratories?
Over the last 52 weeks Dr. Reddy's Laboratories traded between ₹1,101.00 and ₹1,414.90 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Dr. Reddy's Laboratories?
About ₹1,02,340 Cr at the latest price, with a P/E of 32.0, a price-to-book of 2.7, a return on equity of 8.5%. Ratios use the company's latest reported results.
Who owns Dr. Reddy's Laboratories shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 26.63%, foreign institutions 31.39%, domestic institutions 31.88%.
Is Dr. Reddy's Laboratories traded in futures and options?
Yes, DRREDDY is in NSE's futures and options segment. The lot size is 625 shares.
Which sector and indices does Dr. Reddy's Laboratories belong to?
NSE classifies Dr. Reddy's Laboratories under Healthcare; it is a member of Nifty 50, Nifty 100, Nifty 500.
Follow Dr. Reddy's Laboratories with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Get started free